NCT00101803View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

527

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY